BlackRock Fund Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

BlackRock Fund Advisors’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$79.3M	Sell	5,984,758 -461,821	-7%	-$7.9M	0.01%	1378
2016 Q3	$153M	Buy	6,446,579 +649,256	+11%	+$17.4M	0.03%	733
2016 Q2	$167M	Buy	5,797,323 +185,241	+3%	+$6.04M	0.04%	608
2016 Q1	$180M	Buy	5,612,082 +128,019	+2%	+$4.5M	0.04%	541
2015 Q4	$234M	Sell	5,484,063 -117,670	-2%	-$4.7M	0.05%	402
2015 Q3	$197M	Buy	5,601,733 +221,157	+4%	+$9.96M	0.05%	437
2015 Q2	$247M	Buy	5,380,576 +72,986	+1%	+$3.46M	0.06%	374
2015 Q1	$249M	Buy	5,307,590 +289,794	+6%	+$11.5M	0.06%	377
2014 Q4	$159M	Buy	5,017,796 +319,336	+7%	+$9.35M	0.04%	593
2014 Q3	$111M	Buy	4,698,460 +16,372	+0.3%	+$419K	0.03%	755
2014 Q2	$140M	Sell	4,682,088 -265,207	-5%	-$7.15M	0.04%	622
2014 Q1	$131M	Buy	4,947,295 +161,709	+3%	+$4.04M	0.04%	642
2013 Q4	$120M	Buy	4,785,586 +195,642	+4%	+$4.36M	0.04%	697
2013 Q3	$94M	Buy	4,589,944 +437,784	+11%	+$9.04M	0.03%	800
2013 Q2	$82.8M	Buy	+4,152,160	New	+$73.7M	0.03%	798

Other funds holding IPXL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

BlackRock Fund Advisors's IPXL Position: Q4 2016 in Review

BlackRock Fund Advisors reduced its Impax Laboratories, Inc. (IPXL) stake by 7.2% in Q4 2016, selling an estimated $7.9M and leaving 5,984,758 shares worth $79.3M. The position accounts for 0.01% of the portfolio, ranked #1378.

BlackRock Fund Advisors first reported a position in IPXL in Q2 2013 and has held it in 15 quarters since. The position peaked at $249M in Q1 2015. 198 funds tracked by Wall St. Rank hold IPXL as of Q4 2016.

BlackRock Fund Advisors held 5,984,758 shares of Impax Laboratories, Inc. worth $79.3M as of Q4 2016.
BlackRock Fund Advisors sold 461,821 Impax Laboratories, Inc. shares in Q4 2016, an estimated $7.9M.
Impax Laboratories, Inc. made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1378 holding.
BlackRock Fund Advisors first reported a position in Impax Laboratories, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's Impax Laboratories, Inc. position peaked at $249M in Q1 2015.
198 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.